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Abstract
Background: Gastroesophageal reflux disease imposes a significant burden of illness in Western populations.
However, data on the impact of reflux symptoms on daily life in Asian populations are scarce. The current study
aimed to evaluate the impact of GERD (defined on the basis of symptoms) on health-related quality-of-life (HRQoL)
in individuals from five regions in China, as part of the Systematic Investigation of Gastrointestinal Diseases in
China (SILC) study.
Methods: In total, 18 000 residents were randomly selected from across five regions of China and asked to
complete a general information questionnaire and a Chinese version of the Reflux Disease Questionnaire (RDQ).
A randomly selected subsample of one-fifth of subjects (20% from each region) completed Chinese versions of the
36-item self-administered (SF-36) questionnaire and Epworth Sleepiness Scale (ESS) questionnaire. Reflux symptoms
were defined as the presence of heartburn and/or regurgitation. Symptom-defined GERD was diagnosed as mild
heartburn and/or regurgitation ≥2 days per week, or moderate/severe heartburn and/or regurgitation ≥1d a ya
week, based on the Montreal Definition of GERD for population-based studies.
Results: The response rate was 89.4% for the total sample (16 091/18 000), and for the 20% subsample (3219/
3600). Meaningful impairment was observed in all 8 SF-36 dimensions in participants with symptom-defined GERD,
in 7 of the 8 SF-36 dimensions in participants with troublesome reflux symptoms, and in 6 of the 8 SF-36
dimensions in participants with reflux symptoms below the threshold for symptom-defined GERD. Meaningful
daytime sleepiness was also observed in each of these groups. The proportion of individuals reporting troublesome
symptoms increased as reflux symptom frequency and severity approached the threshold for symptom-defined
GERD, and this was associated with concomitant decreases in all HRQoL measures. Troublesome symptoms were
reported by 68.2% (75/110) of individuals with symptom-defined GERD.
Conclusions: GERD diagnosed using symptom/frequency criteria (recommended for population-based studies), or
based on troublesome reflux symptoms (recommended for the clinic), is associated with significantly impaired
HRQoL in Chinese individuals. However, patient groups identified using these definitions do not overlap
completely, suggesting that they capture slightly different, though clinically relevant, GERD populations.
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Gastroesophageal reflux disease (GERD) has been shown
to impose a significant and meaningful burden of illness
on individuals in several Western population-based stu-
dies that have used validated questionnaires [1-5].
Indeed, even mild reflux symptoms have been shown to
impair health-related quality-of-life (HRQoL) [1]. The
burden associated with reflux symptoms encompasses
impaired physical activity, psychosocial well-being and
daily functioning, as well as reduced vitality and dis-
turbed sleep [1,3,4]. Impaired HRQoL associated with
reflux symptoms leads to reduced work productivity,
which incurs substantial economic costs [6,7].
Data on the impact of reflux symptoms on HRQoL in
Asian populations are scarce, and cannot be inferred using
data from Western countries because cultural differences
are likely to modulate the impact of reflux symptoms on
daily living. One epidemiological study of GERD in
Guangzhou, South China, evaluated HRQoL impairment
in individuals with GERD using a Chinese version of the
36-item Short-Form Health Survey (SF-36) [8]. Compared
with controls, individuals with GERD in this study experi-
enced considerable impairment in HRQoL, particularly in
the bodily pain, role limitation-physical and role limita-
tion-emotional dimensions. We have previously reported a
pilot population-based study (n = 1034) of the burden of
GERD in Shanghai, China [9] where GERD was associated
with meaningfully reduced HRQoL, particularly with
regard to the bodily pain, general health and role limita-
tion-physical dimensions. T h ec u r r e n ts t u d ya i m e dt o
evaluate the impact of GERD (defined on the basis of
symptoms) on HRQoL in individuals from five regions in
China, and was part of the Systematic Investigation of
Gastrointestinal Diseases in China (SILC) study.
Methods
Setting, sampling and study design
The populations of Shanghai, Beijing, Xi’an, Wuhan and
Guangzhou were selected for sampling in this study.
These regions are major population centres of eastern,
northern, western, central and southern China. The sur-
vey was conducted between April 2007 and January 2008.
As described in detail elsewhere [10], 18 000 residents
of China aged 18-80 years (n = 3600 from each study
region) were randomly selected using a stratified, multi-
stage sampling methodology. Urban and rural popula-
tions were sampled in equal numbers within each study
region. Residents were randomly selected from urban
areas or villages in proportion to the age and gender
distributions for each region, according to population
census statistics published by the government. Three
attempts were made to contact a resident before he or
she was considered to be a non-responder.
All respondents completed a general information
questionnaire and a Chinese version of the Reflux Dis-
ease Questionnaire (RDQ). A randomly selected sub-
sample of one-fifth of subjects (20% from each region)
also completed Chinese versions of the SF-36 and
Epworth Sleepiness Scale (ESS) questionnaire, and
underwent a physical examination.
The study supervisors who developed the surveys and
organized their administration were graduates from the
Department of Health Statistics, Second Military Medi-
cal University in Shanghai, who received training from
gastrointestinal specialists and epidemiologists in Shang-
hai. The study supervisors provided standardized train-
ing for the survey facilitators, who were local university
graduates or social workers from the sampled sites.
Questionnaires were self-administered in local residen-
tial committee offices or in residents’ own homes, and
the survey facilitators were available to explain any
questions that were unclear.
Informed consent was obtained from all subjects, who
were free to discontinue their participation in the study
at any time. The study was approved by the Ethics
Committee of the Second Military Medical University,
Shanghai, China.
Questionnaires
General information questionnaire
The general information questionnaire was used to collect
self-reported data on age, height, weight, sex, marital sta-
tus, education, income, occupation, lifestyle habits, psy-
chological stress, family history of gastrointestinal diseases,
current health status and medical history (self-reported
physician diagnoses and related treatments) [11].
RDQ
The RDQ is a self-report questionnaire that assesses the
presence of heartburn/chest pain, regurgitation and epi-
gastric pain/burning over the previous 4-weeks using a
set of six items (two items per symptom) in relation to
both symptom frequency and severity (12 items total).
Each item is scored on a 6-point Likert scale for fre-
quency (0, no symptoms; 1, symptoms <1 day a week; 2,
symptoms 1 day a week; 3, symptoms 2-3 days a week;
4, symptoms 4-6 days a week; 5, daily symptoms) and
severity (0, no symptoms; 1, very mild symptoms; 2,
mild symptoms; 3, moderate symptoms; 4, moderately
severe symptoms; 5, severe symptoms). The Chinese
RDQ used in the present study had a 1-week recall per-
iod which had credible reliability and construct validity
when used in the pilot study [11].
The RDQ has recently been documented as a diagnos-
tic tool for GERD in patients consulting with upper gas-
trointestinal symptoms in primary care [12] and as a
means of monitoring treatment response [13,14].
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to the Chinese RDQ asking whether the symptoms were
troublesome or not. This question was included because
the Montreal Definition of GERD states that, in the
clinic, GERD should be considered present when the
reflux of stomach contents causes symptoms that
are troublesome [15]. However, the format of the ques-
tionnaire did not allow participants to specify which of
the RDQ symptoms (epigastric, heartburn, regurgitation)
they found troublesome. Therefore, participants in
whom troublesome symptoms were definitely caused by
reflux (i.e. heartburn and/or regurgitation) could only be
identified by excluding all participants with epigastric
symptoms.
SF-36
The SF-36 is a generic 36-item self-administered ques-
tionnaire [16] that measures HRQoL according to
eight dimensions: physical functioning, role limitation-
physical, bodily pain, general health, vitality, social
functioning, role limitation-emotional and mental
health. Raw scores are transformed into a value falling
on a 0-100 scale, with lower scores denoting impaired
HRQoL. The reliability and validity of the SF-36 are
well documented in a range of language versions,
including Chinese [17-19].
ESS questionnaire
The ESS is an eight-item, self-administered questionnaire
used to score the likelihood of daytime sleepiness in
various situations [20]. Responses are scored on a 4-point
Likert scale (3, high risk of dozing; 0, no risk of dozing).
Item scores are summed to produce a final score ranging
from 0 to 24. The reliability and internal consistency of
the ESS has been demonstrated in Australia in English
[21] and in Hong Kong in Chinese [22].
Definitions
Reflux symptoms were defined as the presence of heart-
burn and/or regurgitation. Heartburn was assessed using
the ‘burning behind the breastbone’ and ‘pain behind
the breastbone’ items of the RDQ, and regurgitation was
assessed using the ‘acid taste in your mouth’ and
‘unpleasant movement of materials upwards from the
stomach’ items of the RDQ. Using the Montreal Defini-
tion of GERD for population-based studies, symptom-
defined GERD in the SILC study was diagnosed based
on the presence of mild symptoms of heartburn and/or
regurgitation occurring on at least 2 days per week
(RDQ item severity score of 2 for a frequency score ≥3),
or moderate/severe symptoms of heartburn and/or
regurgitation occurring on at least 1 day per week (RDQ
item severity score ≥3 for a frequency score ≥2) [15].
A meaningful impairment in HRQoL was defined as a
significant (p < 0.05) decrease of ≥5 points in a 100-
point SF-36 dimension [16]. Meaningful daytime
sleepiness was defined as an ESS score of >12 (a score
of 10-12 was borderline and <10 was normal) [20].
Data collection and statistical analysis
Data were collected and validated as previously
described [10]. If 50% or more of items were completed
in one dimension of the SF-36 and ESS questionnaire,
the mean value of the completed items in that dimen-
sion was used to impute any missing values. If more
than 50% of the items were missing, the score was
excluded from the analysis (as recommended in the SF-
36 manual). The SAS 9.1.3 (SAS Institute, Cary, NC,
USA) program was used to analyse the data. We deter-
mined the statistical significance of continuous variables
using t-t e s t so ra n a l y s i so fv a r i a n c e( A N O V A ) .E S S
scores were compared between groups using the
Cochran-Mantel-Haenszel test or Wilcoxon rank sum
test. All of the above hypothesis tests were two-sided,
and a two-tailed p-value of 0.05 or less was considered
to indicate statistical significance.
Results
Response rate and sample characteristics
The response rate was 89.4% (16 091/18 000), and 16
078 responses were suitable for analysis. Demographic
characteristics of the whole study population are
described fully elsewhere [10]. The response rate in the
20% subsample taken across the five SILC study sites
was 89.4% (3219/3600), with sufficient SF-36 data
obtained from 89.3% (3214/3600) of individuals and suf-
ficient ESS data obtained from 88.9% (3200/3600) of
individuals. Where there were not enough data available
for inclusion this was due to logistical errors and/or
insufficient completion of the questionnaire. Character-
istics of the 20% subsample were very similar to those
reported for the study population as a whole (Table 1),
indicating that this is a representative subgroup of the
e n t i r eS I L Cs t u d yp o p u l a t i o n .T h ep r e v a l e n c eo fs y m p -
tom-defined GERD in the subsample (3.4%) was very
similar to that in the total SILC study population (3.1%).
Symptom-defined GERD and HRQoL
In the subsample, subjects with symptom-defined GERD
had meaningfully impaired HRQoL in all eight SF-36
dimensions compared with those without (Figure 1A).
The mean reduction in HRQoL in individuals with
symptom-defined GERD was greater for the role limita-
tion-physical (-21.8 points), general health (-19.1 points),
bodily pain (-18.3 points) and vitality (-15.3 points)
dimensions than for the other four dimensions (range,
-8.8 to -13.1 points). However, the impact of symptom-
defined GERD was not uniform across the five sample
regions. Specifically, only the bodily pain and general
health dimensions were meaningfully impaired by
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points and -12.6 points; p < 0.01), while social function-
ing was not meaningfully impaired in the Beijing region
(-5.9 points; p = 0.11), and physical functioning (-2.8
points; p = 0.30) and role limitation-emotional (-4.2
points; p = 0.58) dimensions were not meaningfully
impaired in the Xian region.
Meaningful daytime sleepiness was significantly more
prevalent among participants with symptom-defined
GERD than among those without (26.6% versus 13.8%;
p < 0.0001) (Figure 2).
Reflux symptom frequency and severity, and HRQoL
Participants with reflux symptoms below the threshold
for symptom-defined GERD (i.e. mild reflux symptoms
<2 days a week or very mild reflux symptoms of any fre-
quency) had meaningfully impaired HRQoL in all SF-36
dimensions except role physical functioning and social
functioning, compared with participants who had no
reflux symptoms (Figure 1B). A clear trend was observed
towards greater impairment in all SF-36 dimensions as
reflux symptom frequency and severity approached the
threshold for symptom-defined GERD (Figure 3A). Parti-
cipants with very mild reflux symptoms of any frequency
had meaningful impairment in six of the eight SF-36
dimensions (physical functioning and social functioning
were not meaningfully impaired) compared with those
without any reflux symptoms, while participants with
mild reflux symptoms <2 days per week had meaningful
impairment in seven of the eight SF-36 dimensions
(physical functioning was not meaningfully impaired).
Meaningful daytime sleepiness was significantly more
prevalent among patients with reflux symptoms below
the threshold for symptom-defined GERD than among
those without reflux symptoms (23.7% versus 12.4%;
p < 0.0001).
Troublesome symptoms and HRQoL
Meaningfully impaired HRQoL was observed in seven of
the eight SF-36 dimensions (physical functioning was
not meaningfully impaired) among individuals in whom
troublesome symptoms were definitely due to reflux (i.e.
patients reporting troublesome symptoms that had
heartburn and/or regurgitation but no epigastric symp-
toms) and the pattern of impairment was similar to that
observed in patients with symptom-defined GERD (Fig-
ure 1C versus Figure 1A). Meaningful daytime sleepiness
was also significantly more prevalent among individuals
with troublesome reflux symptoms (22.1% versus 13.9%;
p < 0.05), than among those without.
The proportion of subjects with symptom-defined
GERD who reported that their symptoms were trouble-
some was 68.2% (75/110) (Figure 3B). When participants
with epigastric symptoms were excluded so that the
term troublesome could be attributed solely to reflux,
this percentage dropped to 56.9% (37/65). Of those par-
ticipants who had reflux symptoms below the threshold
for symptom-defined GERD, 40.0% (142/355) reported
Table 1 Demographic and baseline characteristics of the 20% subsample that completed the SF-36 and ESS
questionnaire, compared with the full study population
Entire SILC study population
N = 16 078
20% subsample
N = 3214
n (%) n (%)
Region
Urban 8072 (50.2) 1585 (49.3)
Rural 8006 (49.8) 1629 (50.7)
Sex
Female 8390 (52.2) 1678 (52.2)
Male 7688 (47.8) 1536 (47.8)
Age (years)
18-29 3680 (22.9) 749 (23.3)
30-39 3675 (22.9) 736 (22.9)
40-49 3812 (23.7) 757 (23.6)
50-59 2468 (15.4) 486 (15.1)
60-69 1503 (9.3) 309 (9.6)
70-80 940 (5.8) 177 (5.5)
Smokers 4431 (27.6) 859 (26.7)
Alcohol consumption (any) 3262 (20.3) 684 (21.3)
Body mass index (kg/m
2; mean ± SD) 22.6 ± 3.3 22.6 ± 3.4
ESS, Epworth Sleepiness Scale; SD, standard deviation; SF-36, 36-item Short-Form Health Survey; SILC, Systematic Investigation of Gastrointestinal Diseases in
China.
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29.9% (76/254) when participants with epigastric symp-
toms were excluded.
The proportion of participants reporting the presence of
troublesome symptoms increased as reflux symptom fre-
quency and severity approached the threshold for symp-
tom-defined GERD (Figure 3B). This trend remained
when participants with epigastric symptoms were
excluded, although the percentage of participants report-
ing their symptoms as troublesome was lower overall.
Discussion
Results in context
In this 20% subsample of the large population-based SILC
study, conducted in five regions of China, GERD (defined
as mild symptoms of heartburn and/or regurgitation
Figure 1 Dimension scores of the 36-item Short-Form Health Survey (SF-36) in A) participants with and without symptom-defined
gastroesophageal reflux disease (GERD), B) participants with and without reflux symptoms below the threshold for symptom-defined
GERD and C) patients with and without troublesome reflux symptoms. PF, physical functioning; RP, role limitation-physical; BP, bodily pain;
GH, general health; VT, vitality; SF, social functioning; RE, role limitation-emotional; MH, mental health. *Meaningful impairment (statistically
significant [p < 0.05] decrease of ≥5 points).
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symptoms of heartburn and/or regurgitation occurring on
at least 1 day a week) was associated with meaningful
impairment in HRQoL. Meaningful impairment in
HRQoL was also observed among participants with reflux
symptoms below the threshold for symptom-defined
GERD (mild reflux symptoms <2 days a week or very mild
reflux symptoms of any frequency), even when only very
mild reflux symptoms were present.
The finding of significantly reduced SF-36 dimension
scores and impaired sleep among participants with
symptom-defined GERD compared with those without
is consistent with the results of the Shanghai pilot study
[9], although the pilot study did not find meaningfully
impaired social functioning in individuals with reflux
symptoms. In addition, the pattern of impairment
observed across the different SF-36 dimensions in the
current study is similar to the pattern observed in the
pilot study and in a previous population-based study
conducted in southern China [8]. It is possible that the
impact of symptom-defined GERD on SF-36 dimensions
such as role limitation-emotional, social functioning,
and mental health, are secondary to its effects on physi-
cal dimensions such as role limitation-physical, bodily
pain and general health, which are likely to occur as a
direct consequence of the painful nature of this disease.
This idea is supported by the greater impact of symp-
tom-defined GERD on the latter SF-36 dimensions com-
pared with the former, and by previous observations of
reduced emotional impairment in patients with GERD
after acid-suppressive therapy [2]. Furthermore, even in
Figure 2 The distribution of Epworth Sleepiness Scale (ESS)
scores (clinically meaningful [>12], borderline clinically
meaningful B1010B1111B1212 and non-clinically meaningful
[<10]) among patients with and without symptom-defined
gastroesophageal reflux disease (GERD).
Figure 3 The relationship between reflux symptom frequency/severity and 36-item Short-Form Health Survey (SF-36) dimension
scores. PF: physical functioning; RP: role limitation-physical; BP: bodily pain; GH: general health; VT: vitality; SF: social functioning; RE: role
limitation-emotional; MH: mental health. † = not meaningfully impaired compared to participants with no reflux symptoms.
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seemed to have a minimal impact on health-related
quality of life, measures of bodily pain and general
health were still meaningfully impaired by this disease.
It is possible that cultural variation may modulate the
impact that physical impairments caused by symptom-
defined GERD can have on other aspects of daily activ-
ity. However, the complexity of the differences between
these regions makes it difficult to provide a specific
explanation for this observation.
Studies within mainland China indicate a link between
the presence of reflux symptoms and stress [23], and
between reflux symptoms and specific mental disorders
such as anxiety and depression [24]. Although prone to
selection bias caused by low response rates (46-63%),
similar findings have also been observed in individuals
in Hong Kong [25-27]. These findings are consistent
with impaired mental health scores in individuals with
symptom-defined GERD in the current study, and in
other studies in which the SF-36 has been used [8,9].
Associations between reflux symptoms and impaired
HRQoL have also been reported in individuals from
Germany, Austria, Switzerland, Sweden (all using the
SF-36) [3,28] and North America (using the 8-item
Short-Form Health Survey) [7]. In addition, severe reflux
symptoms have been associated with anxiety and
depression in Norwegian populations [29]. In the Swed-
ish general population, individuals with reflux symptoms
have been shown to have impaired psychological well-
being (assessed by the Psychological General Well-Being
index) [1], and similar results have been observed in
populations from North America, Europe and Japan
[30,31]. Interestingly, Wiklund et al. (2006) found that
mild reflux symptoms were also associated with
impaired psychological well-being, which is consistent
with impaired mental health scores observed in partici-
pants with mild and very mild reflux symptoms in the
current study.
Clinical implications
The Montreal Definition states that GERD is present
when reflux causes troublesome symptoms that
adversely affect a patient’s well-being, and the symptom
frequency and severity threshold used in the current
study are recommended by the Montreal Definition for
identifying such individuals in population-based studies
[15]. The validity of the Montreal Definition of GERD
for population-based studies is supported in our study
by the observation of meaningfully impaired HRQoL in
individuals with reflux symptoms meeting this defini-
tion. However, in the clinical setting, the Montreal Defi-
nition recommends that patients should determine if
their reflux symptoms are troublesome. In our study, at
least 30% of Chinese participants with heartburn and/or
regurgitation below the threshold for symptom-defined
GERD (Montreal definition for population-based stu-
dies) found these symptoms troublesome and had mean-
ingfully impaired HRQoL, and would therefore be
diagnosed with GERD in the clinic based on the Mon-
treal Definition. Conversely, over 30% of individuals
who met the reflux symptom frequency/severity thresh-
old for symptom-defined GERD did not describe their
symptoms as troublesome and should not be diagnosed
with GERD. It therefore appears that, despite substantial
overlap, GERD populations captured using the Montreal
Definitions of GERD may vary slightly depending on the
version used, although both versions capture individuals
with impaired HRQoL.
Strengths and limitations
The current study is the largest population-based epide-
miological investigation of GERD ever conducted in
China, and spans five major population centres that cap-
ture both rural and urban regions. Further strengths of
this study include the use of validated questionnaires
and a validated survey methodology [11], and the high
response rate, which minimized the potential for
responder bias. Moreover, this is the first ever study to
assess the impact of symptom-defined GERD, as diag-
nosed using the Montreal Definition, on measures of
HRQoL.
One of the limitations of this study was the inability to
distinguish (due to the format of the questionnaire)
which of the three symptom groups (heartburn, regurgi-
tation or epigastric) participants found troublesome.
The only way to identify participants in whom trouble-
some symptoms were definitely caused by heartburn
and/or regurgitation was to exclude participants with
any epigastric symptoms. However, this blunt approach
would have also excluded some individuals whose trou-
blesome symptoms were in fact caused by heartburn
and/or regurgitation, and the size of this group was
therefore probably underestimated.
Another potential limitation of this study is that
impaired HRQoL in patients with symptom-defined
GERD, as measured using the SF-36 and ESS question-
naire, may be related to factors associated with symp-
tom-defined GERD (e.g. other upper gastrointestinal
diseases, anxiety, depression), rather than to the pre-
sence of troublesome reflux symptoms. Arguing against
this possibility is the observation that the proportion of
individuals who reported their symptoms as trouble-
some increased as reflux symptom frequency and sever-
ity approached the threshold for symptom-defined
GERD, and that this was associated with concomitant
decreases in all HRQoL measures. In addition, partici-
pants who described their reflux symptoms as trouble-
some had patterns of impaired HRQoL that were similar
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symptom-defined GERD. These data suggest that
impaired HRQoL in individuals with symptom-defined
GERD, and in patients with reflux symptoms below the
threshold for symptom-defined GERD, was related to
the presence of troublesome reflux symptoms. However,
as with any cross-sectional study, the direction of this
relationship could not be assessed.
Future work
Further research is needed to assess how reflux symp-
tom type, frequency and severity influences treatment
outcomes and consultation behaviour in Chinese indivi-
duals. In addition, correlating therapy-induced improve-
ments in reflux symptoms with improved HRQoL would
help to clarify the directionality of the relationship
between reflux symptoms and impaired HRQoL in this
population. Finally, population-based studies using the
Montreal Definition of GERD also need to be conducted
in Western countries to allow a direct comparison of
the impact of symptom-defined GERD on daily life
between these culturally distinct populations.
Conclusion
GERD diagnosed based on symptom/frequency criteria
(recommended by the Montreal Definition for use in
population-based studies), or based on the presence of
troublesome reflux symptoms (recommended by the
Montreal Definition for use in the clinic), is associated
with significantly impaired HRQoL in Chinese indivi-
duals. Groups identified using these definitions do not
overlap completely, suggesting that they capture slightly
different, though clinically relevant, GERD populations.
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